A new Covid variant is ripping through “multiple countries”, with experts fearing it could be even more transmissible than the BA. 5 Omicron strain. Named BF. 7 – short for BA. 5.2.1.7 – the new variant is spreading faster than most other variants of interest that scientists are currently tracking in the US. While it […]
Scientists on alert as new Covid strain tears through ‘multiple countries’ Read More »
Key Points Question What is the association between 3 doses of mRNA COVID-19 vaccine and symptomatic SARS-CoV-2 infection with the Omicron and Delta variants? Findings In this test-negative case-control analysis that included 70 155 tests from symptomatic adults, the likelihood of vaccination with 3 mRNA vaccine doses (vs unvaccinated) was significantly lower among both Omicron (odds ratio, 0.33)
SARS-CoV-2 variants have become a major virological, epidemiological and clinical concern, particularly with regard to the risk of escape from vaccine-induced immunity. Here we describe the emergence of a new variant. For twelve SARS-CoV-positive patients living in the same geographical area of southeastern France, qPCR testing that screen for variant-associated mutations showed an atypical combination.
Abstract COVID-19 is known to cause multi-organ dysfunction1-3 in acute infection, with prolonged symptoms experienced by some patients, termed Post-Acute Sequelae of SARS-CoV-2 (PASC)4-5. However, the burden of infection outside the respiratory tract and time to viral clearance is not well characterized, particularly in the brain3,6-14. We performed complete autopsies on 44 patients with COVID-19 to
SARS-CoV-2 infection and persistence throughout the human body and brain Read More »
Background: Patients with COVID-19 present with a variety of clinical manifestations, ranging from mild or asymptomatic disease to severe illness and death. Whilst previous studies have clarified these and several other aspects of COVID-19, one of the ongoing challenges regarding COVID-19 is to determine which patients are at risk of adverse outcomes of COVID-19 infection.
Heart-rate-variability (HRV), predicts outcomes in COVID-19 Read More »
HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung 15 December 2021 A study led by researchers from the LKS Faculty of Medicine at The University of Hong Kong (HKUMed) provides the first information on how the novel Variant of Concern (VOC) of
Hong Kong Omicron Research on Viral Replication Read More »
Omicron in South Africa December 13, 2021 – When it comes to the spread of the Omicron variant — and understanding it — South Africa is a step ahead of the rest of the world. Since the detection of the variant in November, coronavirus cases have skyrocketed. On Sunday, the country’s president tested positive for the virus.
OMICRON UPDATE AND SOUTH AFRICAN VIDEO BRIEFING NOVEMBER 2021 Read More »
On Friday, the WHO said the number of cases of this variant, initially named B.1.1.529, appeared to be increasing in almost all of South Africa’s provinces. “This variant has a large number of mutations, some of which are concerning,” the UN public health body said in a statement. It said “the first known confirmed B.1.1.529 infection was from a
Omicron: ‘Bad news – but not doomsday.’ Read More »
journal homepage: journal homepage: www.jcimjournal.com/jim www.journals.elsevier.com/journal-of-integrative-medicine CC BY 2.0 Abstract There is currently no drug or therapy that can cure the coronavirus disease 2019 (COVID-19), which is highly contagious and can be life-threatening in severe cases. Therefore, seeking potential effective therapies is an urgent task. An older female at the Leishenshan Hospital in Wuhan, China, with
A letter from Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health I write to announce a major new NIH initiative to identify the causes and ultimately the means of prevention and treatment of individuals who have been sickened by COVID-19, but don’t recover fully over a period of a few weeks. Large numbers
NIH launches new initiative to study “Long COVID” Read More »
